Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer

NCT04196075 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04196075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04196075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2018
Completion date
June 30, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of esophagus